Rosa Tamara Branca1,2, Le Zhang3,4, Alex Burant1,4, Laurence Katz5, and Andrew McCallister1,4
1Physics and Astronomy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 2Biomedical Research Imaging Center, Chapel Hill, NC, United States, 3Material Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 4Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 5Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Synopsis
Despite
histological evidence that all humans have brown adipose tissue, the detection
of this tissue in overweighs and obese subjects has proven to be a challenge. A
recent study showed that MRI by hyperpolarized xenon gas (HP129Xe) enables the
detection of this tissue in both lean and obese animal phenotype, with enhanced
sensitivity in the latter with respect to the gold standard, FDG-PET. Here we
demonstrate that HP129Xe gas MRI can also be used to detect human BAT with
better sensitivity than FDG-PET.Purpose
Recent studies have shown that Brown Adipose Tissue1 (BAT) plays a regulatory
role in human energy balance and glucose homeostasis and may have a protective
role against obesity and diabetes as it has in mice[2,3]. As new therapeutic treatments
that specifically target this tissue are being developed, non-invasive
detection of BAT tissue and thermogenic activity remains an unmet need,
especially in obese and overweight subjects[4–6].
Recently we
demonstrated that magnetic resonance with HyperPolarized 129Xe gas (HP129Xe)
can be used in rodents to detect BAT mass with better sensitivity than FDG-PET
for the lipid-rich and thermogenically inactive BAT of obese mice[7]. Here we present our first preliminary results
on the detection of human BAT by HP129Xe MRI with validation by FDG-PET/ MRI.
Method
Six
healthy volunteers, between the age of 20-53 and with a BMI ranging between 19
and 28, underwent a xenon/1H MRI scan followed by a FDG-PET/1H-MRI scan. The 129Xe/1H MRI scan was performed on a 3T TIM-Trio System (Siemens Medical
Solutions, Erlangen, Germany) by using a dual tuned 129Xe/1H surface coil (8 cm
diameter). Anatomical images as well as 129Xe spectra and images were acquired
both at thermoneutrality and during mild cold exposure, achieved by using
MR-compatible water-perfused cooling pads. For the acquisition of 129Xe spectra
and images, subjects inhaled 600ml of isotopically enriched xenon (∼86% 129Xe), polarized up to 10% by using a commercial
polarizer (Polarean, Inc., Research Triangle Park, NC), and held their
breath for 15-20s . Spectra were collected from the beginning of the
breath hold up to 1 minute, while xenon images were acquired once, after gas
exhalation. The FDG-PET/1H MRI scan was performed within 24 hours from the
129Xe/1H MRI scan, on a Biograph mMR (Siemens Healthcare, Erlangen, Germany). For this study, subjects
were exposed to mild cold for 1 hour before the injection of 500mCi of FDG and
for 45-60 minutes before the acquisition of static FDG-PET images. 1H MRI
images acquired on the 3T and on the Biograph using the same sequences and
parameters were used for co-registration of the 129Xe scan with the FDG-PET
scan.
Results
Figure
1 shows a FDG-PET SUV map, a axial 1H fat images, and fused PET/MRI axial image
acquired on the Biograph along with a 1H fat image and 129Xe spectra acquired at
3T using the dual tuned surface coil at thermoneutrality and during cold
exposure. The xenon spectrum acquired at thermoneutrality shows only the
gas-phase xenon resonance, whereas the xenon spectrum acquired during cold
exposure shows the appearance of two dissolved-phase resonances: a narrow peak
around 190ppm, which lasted for several seconds after gas exhalation,
corresponding to xenon dissolved in lipids, and a broader peak around 200ppm,
corresponding to xenon dissolved in blood plasma, which disappeared few seconds
after exhalation. Comparison of the 1H images acquired on the 3T and those
acquired on the PET/MRI scanner clearly shows that the sensitive region of the
surface coil from which 129Xe spectra were acquired contains metabolically
active BAT. Figure 2 shows a HP129Xe image, acquired several seconds after gas
exhalation, fused to the corresponding anatomical 1H image, along with the
fused FDG-PET/1H image. This image shows a clear selective uptake of xenon in
the supraclavicular fat pads, which also shows enhanced glucose uptake.
Discussion
Our preliminary studies in humans mirror the results obtained in mice[7] in
that they show a specific and strong increase in the downstream accumulation of
inhaled HP129Xe in BAT during stimulation of thermogenesis by cold exposure. The
increase in xenon uptake by BAT is such that imaging of BAT by HP129Xe MRI
became feasible. The presence of a blood-dissolved peak during cold exposure
reflects the expected increase in tissue perfusion during thermogenic activity,
which leads to the increased accumulation of 129Xe into BAT.
The increase in the
dissolved–phase signal was seen only during cold exposure and in all subject
analyzed, despite two of them turning up BAT-negative on FDG-PET scans. On the
other hand, the relative intensity of blood/lipid peak varied greatly across
our subjects and seemed to be correlated with tissue hydration and perfusion.
Conclusions
We have
demonstrated detection of BAT by 129Xe/MRI in humans. As already demonstrated in
mice, this technique seems to be more sensitive than FDG-PET to the lipid rich
and thermogenically less active BAT characteristic of obese phenotype,
underlying the well known limitations of FDG-PET scans for the detection of
human BAT and finally enabling the detection of this tissue in overweight and
perhaps obese subjects, the target population for anti-obesity therapies that
aim to target BAT.
Acknowledgements
This work was supported by the North Carolina National Center for Advancing Translational Sciences (NCATS), through NIH grant award UL1TR001111, and by the NIDDK through grant award R01 DK108231References
1. Cannon, B. & Nedergaard, J. Brown
adipose tissue: function and physiological significance. Physiol Rev 84,
277–359 (2004).
2. Ouellet, V. et al. Brown adipose
tissue oxidative metabolism contributes to energy expenditure during acute cold
exposure in humans. J. Clin. Invest. 122, 545–552 (2012).
3. Chechi, K., Nedergaard, J. &
Richard, D. Brown adipose tissue as an anti-obesity tissue in humans. Obes.
Rev. 15, 1–15 (2013).
4. Matsushita, M. et al. Impact of
brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int.
J. Obes. (Lond). 38, 1–6 (2013).
5. Vijgen, G. H. E. J. et al. Brown
adipose tissue in morbidly obese subjects. PLoS One 6, 2–7
(2011).
6. Cypess, A. M., Haft, C. R., Laughlin, M.
R. & Hu, H. H. Brown fat in humans: consensus points and experimental
guidelines. Cell Metab. 20, 408–15 (2014).
7. Branca, R. T. et al. Detection of
brown adipose tissue and thermogenic activity in mice by hyperpolarized xenon
MRI. Proc. Natl. Acad. Sci. 111, 18001–18006 (2014).